Cancer Immunotherapy Update: Latest Advances in Patient Care, with Dr. Jedd D. Wolchok

In this webinar for patients and caregivers interested in learning about cancer immunotherapy, our invited expert, Dr. Jedd Wolchok, discusses the latest developments in patient care including: checkpoint blockade, cancer vaccines, combination therapies, CAR T cell therapy, T cell receptor therapies, neoantigens, and more.

Jedd D. Wolchok, M.D., Ph.D., is the Lloyd J. Old/Virginia and Daniel K. Ludwig chair in clinical investigation; chief, Melanoma & Immunotherapeutics Service; director, Parker Institute for Cancer Immunotherapy; and associate director, Ludwig Center for Cancer Immunotherapy, all at Memorial Sloan Kettering Cancer Center in New York City. He is an associate director of CRI's Scientific Advisory Council and director of CRI's clinical investigation program.

The "Cancer Immunotherapy and You" webinar series is produced by the Cancer Research Institute and is made possible with generous support from Bristol-Myers Squibb, with additional support from Regeneron, Sanofi Genzyme, and Adaptimmune.